Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05755542
Other study ID # Covid Outcome
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date March 20, 2023
Est. completion date November 1, 2023

Study information

Verified date March 2023
Source Rehazentrum Walenstadtberg
Contact Jaroslaw A Dudczak, MD
Phone 0041793414160
Email jaroslaw.dudczak@kliniken-valens.ch
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the first study is to investigate how often a long Covid syndrome occurs after an inpatient rehabilitation due to previous hospitalization because of after acute Covid and whether there might be a connection with the severity during acute illness. 3 clusters of acute cases have been identified to be studied with regard to the long-term symptoms 1. Mild course (medication, oxygen) 2. Moderate course (IPS-IMC with NIV but without intubation) 3. Severe course (intubation) The aim of the second study is to use a catamnestic survey and subsequent evaluation of the information to gain an insight into the existing functional deficits relevant to everyday life and restriction of the ability to participate in the workplace after rehabilitation treatment. The assessment of functional deficits is carried out in relation to: 1. Deficits in everyday skills (ADLs) 2. Restrictions in the ability to participate in the profession.


Description:

All patients who had been infected with Walenstadtberg after acute Covid infection were included. Patients were hospitalized for inpatient rehabilitation in the period from 01.04.2020 to 30.06.2022. A written follow-up survey was carried out with regard to a possible persistent long Covid symptoms and possible persistent deficits in everyday skills and Restrictions in the ability to participate in the profession. There are 2 cohort studies.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 500
Est. completion date November 1, 2023
Est. primary completion date September 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - >18 years of age - treated at a rehabilitation facility after being hospitilized for covid-19 infection - complete questionnaire - written consent to use collected data Exclusion Criteria: - < 18 years - incomplete questionnaire

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Rehazentrum Walenstadtberg

Outcome

Type Measure Description Time frame Safety issue
Primary Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment 2 years
Primary Occurance of deficits in managing everyday life and work after covid infection Investigation of deficits experienced by patients who have been treated at a rehabilitation facility after beeing hospitilized for a covid-19 infection and the impact of these deficits in everday life as well as in the workplace 2 years
Secondary reinfection with covid-19 after rehabilition treatment reinfection with covid-19 after rehabilition treatment 2 years
Secondary Impact of Covid-19 infection on quality of life Impact of Covid-19 infection on quality of life in patients who have been treated at a rehabilition facility after beeing hospitilized due to a covid-19 infection 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT05926505 - Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome Phase 2/Phase 3
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Completed NCT05552612 - Health-related Quality of Life and Long COVID
Completed NCT05531019 - COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A N/A
Not yet recruiting NCT04949386 - Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms. Phase 2
Recruiting NCT06118112 - Living With Long COVID: LONGCOVID-EXPERIENCE
Completed NCT05185674 - Sociodemographic, Clinical, Quality of Life and Health Care Conditions in COVID-19 Survivors.
Active, not recruiting NCT05965739 - RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms N/A
Active, not recruiting NCT05965752 - RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms N/A
Completed NCT05812209 - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Recruiting NCT05606211 - Pain in Long COVID-19: The Role of Sleep
Active, not recruiting NCT05713266 - Using Data From a Multisensor Rapid Health Assessment Device to Predict Decompensation in Long COVID (AIDI)
Completed NCT05679505 - Vagus Nerve Stimulation for Post-COVID Syndrome N/A
Completed NCT05601180 - Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID. N/A
Not yet recruiting NCT06045338 - Mind Body Intervention for Long COVID N/A
Recruiting NCT06091358 - Inspiratory Muscle Training in People With Long COVID-19- A Pilot Investigation. N/A
Recruiting NCT05566392 - Longterm Influence of Pediatric Long COVID Syndrome
Recruiting NCT05855369 - Smell Training and Trigeminal Nerve Stimulation for COVID-related Smell Loss Phase 2/Phase 3
Recruiting NCT05572346 - Digital App for Telerehabilitation in Respiratory Diseases
Recruiting NCT06316843 - Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2 Phase 2